| Tool Translational Research Projects | Stanford University | Purification of Human Hematopoietic Stem Cells (HSCs) for Clinical Stem Cell Transplantation |
$1,347,722 |
| Tools and Technologies III | Stanford University | Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp… |
$1,271,952 |
| Conference | International Society for Stem Cell Research | ISSCR 8th Annual Meeting – San Francisco |
$62,475 |
| Disease Team Therapy Development III | Stanford University | Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors |
$6,505,568 |
| Tools and Technologies II | Stanford University | Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs |
$1,463,814 |
| Comprehensive Grant | Stanford University | Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells |
$2,471,386 |
| Disease Team Research I | Stanford University | Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$18,759,276 |
